HomePharma & Biotech

Pharma & Biotech

Outlook Therapeutics: A Hollow 16% Rally Sets Up a July of Binary Decisions

Nasdaq July 13, 2026

Ocugen’s Gene-Therapy Pipeline: Three BLAs, One Platform, and a 670% Analyst Gap

Healthcare July 13, 2026

BioNTech Nears a Crossroads: Factory Closures, Founder Exits, and a Cancer-Pipeline Bet Are All Converging

Analysis July 12, 2026

Bayer Secures €3 Billion Lifeline From Apollo While Pushing to Dismiss Thousands of Roundup Cases

Chemicals July 12, 2026

BioNTech’s Pivotal Week: A Legal Win, Factory Talks with Moderna, and a Looming Leadership Void

Mergers & Acquisitions July 11, 2026

Bayer’s Supreme Court Win Ignites a Landmark Rally — But the Legal Shadow Is Far From Lifted

DAX July 11, 2026

Ocugen: Insider Buying Signals Confidence as Short Sellers Circle and Pipeline Nears Critical Data

Analysis July 10, 2026

BioNTech Prepares for a Pivotal Year: Seven Late-Stage Trials, Cost Cuts, and a Change at the Helm

Healthcare July 9, 2026

1...161718...106 Page 17 of 106